Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Ascending Doses BCD-261 in Healthy Subjects

NCT06715540 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BCD-261, dose 1
DRUG: BCD-261, dose 2
DRUG: BCD-261, dose 3
DRUG: BCD-261, dose 4
DRUG: BCD-261, dose 5
DRUG: BCD-261, dose 6
DRUG: BCD-261, pre-specified therapeautic dose X
DRUG: BCD-261, pre-specified therapeautic dose X
DRUG: BCD-261, pre-specified therapeautic dose Y

Sponsor

Biocad